Cargando…
ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines
The luminal B molecular subtype of breast cancers (BC) accounts for more than a third of BCs and is associated with aggressive clinical behavior and poor prognosis. The use of endocrine therapy in BC treatment has significantly contributed to the decrease in the number of deaths in recent years. How...
Autores principales: | Udu-Ituma, Sandra, Adélaïde, José, Le, Thi Khanh, Omabe, Kenneth, Finetti, Pascal, Paris, Clément, Guille, Arnaud, Bertucci, François, Birnbaum, Daniel, Rocchi, Palma, Chaffanet, Max |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384502/ https://www.ncbi.nlm.nih.gov/pubmed/37514116 http://dx.doi.org/10.3390/pharmaceutics15071930 |
Ejemplares similares
-
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
por: Nguyen, Dang Tan, et al.
Publicado: (2021) -
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
por: Sircoulomb, Fabrice, et al.
Publicado: (2011) -
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
por: Sircoulomb, Fabrice, et al.
Publicado: (2011) -
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
por: Sabatier, Renaud, et al.
Publicado: (2014) -
Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2011)